Source Data Verification by CRAs: A Step-by-Step Guide

Introduction to SDV: A Critical CRA Responsibility

Source Data Verification (SDV) is a cornerstone activity for Clinical Research Associates (CRAs) during site monitoring visits. It involves comparing the original source documents maintained at the investigational site with the data transcribed into the Case Report Form (CRF)—whether on paper or in an Electronic Data Capture (EDC) system. This process ensures accuracy, reliability, and compliance with Good Clinical Practice (GCP) guidelines.

For a CRA, conducting SDV isn’t just about ticking off checkboxes—it’s about safeguarding the integrity of the clinical trial by validating what was documented actually happened. This article provides a structured tutorial on how CRAs plan, perform, document, and follow up on SDV activities.

1. Preparing for Source Data Verification

Prior to arriving at a site, CRAs should gather relevant documents and tools for efficient SDV execution. This includes:

• ✅ Latest Monitoring Visit Report (MVR)
• ✅ Patient enrollment log and visit schedules
• ✅ Access rights to Electronic Health Records (EHR)
• ✅ Protocol and CRF versions
• ✅ ALCOA checklist to ensure data traceability

CRAs should also confirm site availability of medical records, lab reports, ECGs, imaging records, and source worksheets. As per PharmaSOP.in, a pre-visit SDV plan helps in identifying high-risk areas such as adverse events, informed consent, and IP accountability.

2. Understanding the Source and CRF Relationship

CRAs need to recognize the original location of data—referred to as the source. This could be:

• ✅ Progress notes in hospital EHR
• ✅ Lab reports from central/local labs
• ✅ Patient diaries or ePROs
• ✅ Nursing charts for vital signs
• ✅ Pharmacy dispensing logs

The CRA must ensure that each data point entered in the CRF matches exactly with the source, noting any inconsistencies. When discrepancies occur, site staff are queried and corrections are documented with audit trails.

3. Executing SDV on Site: Real-World Steps

Upon arriving at the site, the CRA typically:

• ✅ Verifies the informed consent form (ICF) completion and version used
• ✅ Compares subject ID and visit dates across source and CRF
• ✅ Cross-checks vital signs, lab values, ECGs, and AEs from source to CRF
• ✅ Reviews drug administration times and storage conditions
• ✅ Checks protocol deviations and medical history consistency

For example, if Visit 2 was on Jan 18 and the blood pressure was 138/84 mmHg on source but CRF shows 128/88, the CRA will note the discrepancy, raise a query, and track resolution.

4. Documentation and SDV Logs

CRAs maintain SDV logs listing subjects reviewed, sections verified, queries raised, and resolutions. This may be recorded in:

• ✅ Sponsor-provided SDV tracking forms
• ✅ Electronic monitoring visit reports
• ✅ Site Follow-Up Letters (SFUL)

Each CRA should use ALCOA-C principles to evaluate data—Attributable, Legible, Contemporaneous, Original, Accurate, and Complete. For example, if a vital sign entry is recorded 2 days post-visit, this must be flagged and reviewed for compliance risks. Check regulatory expectations in ICH E6 (R2).

5. Handling Discrepancies and Queries

When discrepancies between source data and CRFs arise, CRAs initiate data queries via the EDC system or manual forms. Proper documentation and communication with site staff are essential.

Common Scenarios:

• ✅ Wrong visit date recorded in the CRF
• ✅ Lab values transcribed incorrectly (e.g., glucose: 126 mg/dL entered as 162)
• ✅ Missing or illegible physician signature on progress notes
• ✅ Adverse event not recorded in source but reported in CRF

Each case should be followed with an audit trail, CRA signature, date, and a response from the site. Timeliness and completeness of resolution are tracked in the monitoring visit report (MVR).

6. Source Data Verification in EDC vs. Paper-Based Trials

With growing adoption of EDC platforms, SDV has become more streamlined. However, CRAs must understand both systems:

• ✅ EDC Trials: Real-time query generation, audit trail features, subject visit timestamps
• ✅ Paper Trials: Manual cross-checking, ink-signed corrections, physical storage of SDV logs

In hybrid trials, the CRA often toggles between EHR printouts and eCRFs. Audit preparedness requires verifying source availability and ensuring documents are locked/stamped as verified.

7. Risk-Based Monitoring (RBM) and Partial SDV

Many sponsors now follow Risk-Based Monitoring (RBM) frameworks, wherein 100% SDV is not mandatory. Instead, high-risk data—such as primary endpoints, SAEs, and informed consent—is prioritized.

Examples of Prioritized SDV in RBM:

• ✅ Eligibility criteria fulfillment
• ✅ First dose administration accuracy
• ✅ Serious adverse event (SAE) reporting
• ✅ Final visit efficacy data

This approach saves time while maintaining GCP compliance. Sponsors are guided by centralized data checks and CRA feedback loops to determine SDV intensity.

8. Audit Readiness and SDV Best Practices

SDV documentation is often reviewed during sponsor audits and regulatory inspections. CRAs must ensure:

• ✅ Clear SDV log entries per subject and visit
• ✅ Any deviation noted and escalated appropriately
• ✅ Queries tracked and resolved within timelines
• ✅ Notes-to-File (NTF) generated where needed

One example from ClinicalStudies.in highlighted a CRA’s SDV log flagging backdated vital signs, which led to an internal CAPA and staff retraining at the site. This proactive SDV helped prevent a future FDA 483 observation.

Conclusion

CRAs play a pivotal role in ensuring data credibility through Source Data Verification. Their work directly influences the reliability of trial outcomes and regulatory approvals. By mastering the art of SDV—from planning to documentation—CRAs become the gatekeepers of integrity in clinical trials.

References:

• PharmaValidation: GxP Blockchain Templates
• FDA – SDV and Monitoring Guidance
• PharmaSOP: SDV Visit Checklists
• ICH E6 R2 – GCP Guidelines